Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Revenue From Contract With Customer [Abstract]

Schedule Of Collaboration Revenue

Revenue was as follows for the three months ended March 31, 2023 and 2022:

	Three Months Ended March 31,
	2023		2022
Neurocrine Biosciences:
Recognition of the transaction price	$	—	$	372
Research and development services		—		1,270
Milestone payments		—		7,124
Total revenue	$	—	$	8,766